UK Clinicians Call for Urgent Modernization of NHS EHR Systems to Align With Global Healthcare IT Advancements, Black Book Survey Finds

December 11, 2024 11:30 AM

Over the past eleven months, Black Book Research conducted an extensive series of global surveys as part of the 2025 Black Book of Global Healthcare IT, uncovering widespread dissatisfaction among clinicians and hospital staff with Electronic Health Record (EHR) systems across the NHS in Scotland, England, and Wales. These findings expose critical challenges while presenting actionable strategies to enhance user satisfaction and EHR performance....

Read more

Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025

December 11, 2024 11:00 AM

STATEN ISLAND, NY / ACCESSWIRE / December 11, 2024 / Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQ:ACXP), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that David P. Luci, President & Chief Executive Officer, will be presenting at The Microcap Conference, which will take place January 28 to January 30, 2025 at the Borgata...

Read more

Rymedi and Public Good Pharma / Crowd Funded Cures Announce Strategic Partnership to Improve Access to Medicine by leveraging Web 3.0-backed Financial Innovation

December 11, 2024 9:45 AM

Rymedi, a leader in clinical data management using blockchain technology, and Public Good Pharma (PGP) a financially-innovative biotech company established by Crowd Funded Cures, a registered charity and early DeSci pioneer, today announced a strategic partnership to revolutionize medicine accessibility. Key Highlights of the Partnership:Clinical Data Management: Rymedi hosts clinical trial data on the blockchain for secure, auditable and...

Read more

Belhaven Biopharma Set to Unveil Promising Nasdepi(R) Data at DDL 2024

December 11, 2024 9:30 AM

Belhaven Biopharma, a leader in nasal drug delivery and severe allergy treatment, is set to present new research findings on Nasdepi®, its innovative dry powder nasal epinephrine product, at the 35th annual Drug Delivery to the Lungs (DDL) Conference in Edinburgh, Scotland. The presentation, titled "Investigation of the Impact of Particle Size and Patient Factors on the Nasal Deposition of a Life-Saving Epinephrine Product (Nasdepi®)," will take...

Read more

Clearstep Chosen to Provide the AI-Powered Smart Routing Engine for the Defense Health Agency’s New Digital Front Door

December 11, 2024 8:07 AM

Clearstep, a leading innovator in AI-powered smart access, triage, healthcare navigation, and capacity optimization, has been selected by the Defense Innovation Unit (DIU) and the Defense Health Agency (DHA) to power the smart routing engine of the Military Health System's (MHS) new Digital Front Door. This groundbreaking initiative aims to revolutionize healthcare access and delivery for 9.5 million military beneficiaries.As one of only four...

Read more

CBD Life Sciences Inc. (CBDL) Looking to Acquire a Cannabis Growth License in North Las Vegas

December 11, 2024 8:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL), a leader in CBD innovation, announces its intent to acquire a cannabis growth license in North Las Vegas, a move that could serve as a transformative step in the company's evolution. With a target business value of $10 million and a projected $5 million in gross revenue by 2025, this acquisition positions CBDL at the forefront of Nevada's thriving cannabis cultivation market, which is projected to surpass...

Read more

NLS Pharmaceutics CEO Issues Letter to Shareholders

December 11, 2024 7:30 AM

NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that its Chief Executive Officer, Alex Zwyer, has issued the following letter to shareholders:Dear Valued Shareholders,As we move forward with exciting developments at NLS,...

Read more

Bioz Partnership Empowers TotalLab to Enhance Research Insights With Citation Data

December 11, 2024 4:00 AM

Bioz, Inc., the pioneer of AI-powered citation management, is proud to announce a new partnership with TotalLab, a leader in data analysis software for scientific applications. By integrating Bioz's advanced citation solutions, TotalLab is now able to enhance its product visibility and engagement within the research community. This partnership empowers TotalLab to leverage powerful citation data to gain deeper insights into how their...

Read more

Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk

December 11, 2024 2:00 AM

Evotec SE (Frankfurt Stock Exchange:EVT)(SDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) announced that its translational drug discovery accelerator with Novo Nordisk, LAB eN², which aims to nurture early research from academic institutions into novel therapeutics, has selected its first three projects to move forward in the program from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center....

Read more

Assured Imaging Partners With Advantia Health to Bring Advanced 3D Mammography Services

December 10, 2024 7:45 PM

Assured Imaging, a leading national provider of breast health services, has partnered with Advantia Health to bring state-of-the-art 3D mammography directly to Advantia's offices. This partnership enhances patient care by offering advanced breast imaging services, including 3D screening mammography, diagnostic imaging, breast ultrasounds, Tyrer-Cuzick risk assessments, and AI-driven technology, at four locations in Shiloh, Illinois, and the...

Read more

Growing Demand for Population Health Tools in Asia-Pacific Highlighted in the 2025 Black Book of Global Healthcare IT

December 10, 2024 7:00 PM

MELBOURNE, AUSTRALIA / ACCESSWIRE / December 10, 2024 / The global Population Health Management (PHM) market is poised for extraordinary growth, with its valuation projected to rise from approximately USD 40.0 billion in 2023 to USD 89.3 billion by 2030, at a robust compound annual growth rate (CAGR) of 12.1%. Among the key drivers of this expansion is the Asia-Pacific region, which is expected to account for 33% of global PHM market growth by...

Read more

Dr. Oludotun Olusegun Adegoke Highlights Breakthrough Insights on the Gut-Brain Axis in Alzheimer's Progression

December 10, 2024 6:30 PM

Dr. Oludotun Olusegun Adegoke, a renowned physician and researcher with an extensive background in medicine and clinical research, has shared his latest insights into the role of the gut-brain axis in Alzheimer's disease progression. As an advocate for innovative, holistic approaches to healthcare, Dr. Adegoke underscores the transformative potential of gut microbiota research in addressing the global challenge of Alzheimer's disease.With a...

Read more

Pharmacy Benefit Managers: Driving Cost Savings and Innovation in Healthcare

December 10, 2024 6:00 PM

A pharmacy benefit manager works as a 3rd-party intermediary that helps to find a common ground between drug manufacturers, pharmacies, and healthcare insurance providers. One where prices for prescription medication are agreeable to each based on their prerogatives, and in a challenging environment for controlling costs given the way the pharmaceutical industry in the USA is so wholly geared for profit. Having a pharmacy in Canada serving as a...

Read more

Formula Wellness Partners with The MedSpa Austin, Led by Renowned Plastic Surgeon Dr. Jennifer Walden

December 10, 2024 3:00 PM

Formula Wellness is proud to announce its strategic partnership with The MedSpa Austin, a premier medical spa with two flagship locations: The MedSpa Westlake and The MedSpa Northwest Hills. This collaboration marks a significant milestone as Formula Wellness continues to integrate comprehensive wellness and advanced aesthetic services, furthering its mission to optimize the health, appearance, and longevity of patients nationwide.At the heart...

Read more

World’s largest Psychedelic Church to Close SF Site in Coming Weeks Pastor Cites Harassment from City Planning Department

December 10, 2024 2:20 PM

Zide Door, the psychedelic church garnering national recognition for its devotion to the spiritual power of psilocybin mushrooms, will close its San Francisco location by the end of this year - the victim of a city planning department bent on expelling the institution, Pastor Dave Hodges said Tuesday.Church of Ambrosia, which opened Zide Door April 15, 2023, will continue to serve all 120,000 church members at its founding site in Oakland, he...

Read more

Echo IQ Signs Integration Agreement With Flagship US Hospital

December 10, 2024 2:00 PM

Integration follows successful trial of EchoSolv-AS by Beth Israel researchers on a historical cohort of 31,000 patientsTrial successfully validated the technology's key performance metrics, accuracy and potential to identify additional patients with Aortic Stenosis (AS)Beth Israel Deaconess Medical Centre (BIDMC) is a world-renowned health facility of the Harvard Medical SchoolThe organization undertakes 30,000 echoes annuallySYDNEY, AUSTRALIA...

Read more

U.S. Top Medical Doctors Partner With Known Co-Founder Kourtney Simmang to Launch Kale Health: A Functional Health Innovation

December 10, 2024 2:00 PM

Kale Diagnostics, founded by Kourtney and Stephen Simmang, is evolving into Kale Health with a groundbreaking approach to healthcare. By combining cutting-edge functional health practices with support from the nation's top medical doctors, Kale Health aims to redefine personalized care and empower clients across the country.Kale Diagnostics has been committed since its founding to empowering individuals to take control of their health by...

Read more

Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress

December 10, 2024 12:50 PM

WELLINGTON, FL and HIGHLANDS RANCH, CO / ACCESSWIRE / December 10, 2024 / Cellev8 Nutrition Inc. (OTC Pink:CELV) and Vivos Therapeutics, Inc. today announced a strategic joint marketing venture aimed at providing comprehensive solutions for patients with obstructive sleep apnea (OSA) and associated oxidative stress. This collaboration combines Vivos Therapeutics' FDA-cleared oral medical devices for treating moderate to severe OSA in children...

Read more

Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN

December 10, 2024 11:45 AM

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO), the biopharmaceutical company developing innovative therapies for blood diseases, wishes to provide a further update on the admission of the New Ordinary Shares (as defined below) further to the passing of all resolutions at its Extraordinary General Meeting (the "Meeting") held on 9 December 2024.At the Meeting, resolutions were passed to approve the...

Read more

The Vital Role of Pulmonary Rehabilitation Programs

December 10, 2024 11:00 AM

Pulmonary rehabilitation programs are highly effective for the treatment and rehabilitation of patients with cardiopulmonary disorders. In fact, pulmonary rehabilitation can significantly improve the quality of life for people with chronic lung disease, reduce exacerbations, and lower healthcare costs.Typically, programs include diagnostic testing, therapeutic exercises, educational training and outcomes assessment as part of the patient's...

Read more